Skip to main content

Advertisement

SpringerLink
Log in

Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities

  • Short Communication
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

We compared the levels of AURKA and AURKB in 24 (mantle cell lymphoma) MCL patients harboring 8q abnormalities and its relationship with MYCC gene status. Two distinct subgroups were observed, in terms of MYCC expression. Except for the patients with Burkitt’s-like translocation, none of the patients harboring 8q abnormalities, including balanced translocations or duplications of MYCC band, identified both by G-banding and SKY, showed differential expression levels of MYCC. These previous findings also reflected in the differential expression of AURKA and AURKB genes. We found that AURKA and AURKB mRNA were expressed at significantly higher levels in MCL patients harboring Burkitt’s-like translocation, when compared to patients with 8q rearrangements. The high expression of aurora kinase genes is reported to be associated with some parameters of clinical oncologic aggressiveness, such as high histological grade, invasion and increased rates of metastasis in several types of cancers. It is possible that in MCL patients expressing abnormal levels of MYCC together with a high expression of AURKA might offer some resistant to the conventional therapy purposes. Thus, aurora kinase inhibitors may also be considered for this specific subgroup on MCL, whose aggressive clinical course resembles high-grade lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Investig. 2012;122(10):3416–23.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Espinet B, Salaverria I, Beà S, et al. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma. Genes Chromosomes Cancer. 2010;49(5):439–51.

    CAS  PubMed  Google Scholar 

  3. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001;2(1):21–32.

    Article  CAS  PubMed  Google Scholar 

  4. Kamada K, Yamada Y, Hirao T, et al. Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis. Oncol Rep. 2004;12(3):593–9.

    CAS  PubMed  Google Scholar 

  5. Lucena-Araujo AR, de Oliveira FM, Leite-Cueva SD, dos Santos GA, Falcao RP, Rego EM. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia. Leuk Res. 2011;35(2):260–4.

    Article  CAS  PubMed  Google Scholar 

  6. Shaffer LG, Slovak ML, Campbell LJ, editors. ISCN 2009: an international system for human cytogenetic nomenclature 2009. Basel: S. Karger; 2009.

    Google Scholar 

  7. Torchia EC, Caulin C, Acin S, Terzian T, Kubick BJ, Box NF, Roop DR. Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma. Oncogene. 2012;31:2680–90.

    Article  CAS  PubMed  Google Scholar 

  8. Oliveira FM, Lucena-Araujo AR, Favarin Mdo C, et al. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH. Exp Hematol. 2013;41(2):198–208.

    Article  PubMed  Google Scholar 

  9. Krystyniak A, Garcia-Echeverria C, Prigent C, Ferrari S. Inhibition of Aurora A in response to DNA damage. Oncogene. 2006;25:338–48.

    CAS  PubMed  Google Scholar 

  10. Courapied S, Cherier J, Vigneron A, et al. Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription factor. Mol Cancer. 2010;9:205.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53−/− cells. EMBO J. 2002;21:483–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Yang S, He S, Zhou X, et al. Suppression of Aurora-A oncogenic potential by c-Myc downregulation. Exp Mol Med. 2010;42:759–67.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Sen S, Zhou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst. 2002;94:1320–9.

    Article  CAS  PubMed  Google Scholar 

  14. Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res. 2004;10:2065–71.

    Article  CAS  PubMed  Google Scholar 

  15. den Hollander J, Rimpi S, Doherty JR, et al. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood. 2010;116:1498–505.

    Article  Google Scholar 

  16. Li D, Zhu J, Firozi PF, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res. 2003;9:991–7.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This investigation was supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo (2011/01647-2) and the National Institute of Science and Technology in Stem Cell and Cell Therapy, Ribeirão Preto, Brazil (Proc. 52462-7/2007-0).

Conflict of interest

All the authors reported no potential conflicts of interest.

Author information

Authors and Affiliations

  1. Faculty of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Prêto, SP, 14049-900, Brazil

    Fábio Morato de Oliveira, Ana Paula Nunes Rodrigues-Alves, Antônio Roberto Lucena-Araújo, Ferdinando de Paula Silva, Fernanda Borges da Silva & Roberto Passetto Falcão

Authors
  1. Fábio Morato de Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Paula Nunes Rodrigues-Alves
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antônio Roberto Lucena-Araújo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ferdinando de Paula Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fernanda Borges da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roberto Passetto Falcão
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fábio Morato de Oliveira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Oliveira, F.M., Rodrigues-Alves, A.P.N., Lucena-Araújo, A.R. et al. Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities. Med Oncol 31, 931 (2014). https://doi.org/10.1007/s12032-014-0931-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0931-6

Keywords

Search

Navigation